Skip to main content
EnglishEN
European Commission logo print header

Widening Sino‐EU policy and research cooperation in Personalised Medicine

Project description

DEENESFRITPL

Fostering EU-China cooperation on personalised medicine

Moving away from a one-size-fits-all approach, personalised medicine has the potential to tailor therapy to achieve the best result for each patient. The aim of personalised medicine is to improve diagnosis and treatment of diseases and strengthen prevention strategies by taking into account the patient’s geno- and phenotypes as well as biomedical, lifestyle and environmental factors. The personalised medicine approach to healthcare has been gaining ground in Europe and China. For that reason, the EU-funded SINO-EU-PerMed project will conduct a mapping of the personalised medicine landscape and stakeholders in China. It will also exchange expertise by organising study visits in China and the EU. Further on technical task forces and a series of targeted workshops will be organised to promote communication and collaboration between experts in the field of personalised medicine in China and the EU. Sino-EU-PerMed aims at connecting International Consortium for Personalised Medicine (ICPerMed) strategies and activities with relevant Chinese stakeholders. ICPerMed is a member state driven initiative of over 40 international ministries and funding agencies.

Objective

Personalised Medicine (PerMed) approaches bring along immense potentials to improve diagnosis and treatment of diseases and prevention strategies by taking into account individuals' geno- and phenotypes, biomedical, life style or environmental data. The International Consortium for Personalised Medicine (ICPerMed) is a member state driven initiative of over 40 international ministries and funding agencies. The European Commission (EC) is an active observer and supports by funding several related projects. ICPerMed aims at aligning efforts in all areas of PerMed by fostering international coordination of research and innovation funding.
To support these efforts “Widening Sino‐EU policy and research cooperation in Personalised Medicine” (Sino-EU-PerMed) aims at connecting ICPerMed strategies and activities with relevant Chinese stakeholders. To achieve this goal the Sino-EU-PerMed will disseminate and coordinate the following activities. Inventory and analysis of the PerMed landscape in China via a mapping. In addition the Sino-EU-PerMed consortium will exchange expertise and experts by workshops and via delegation trips in China and Europe. Thereby we will gain a better mutual understanding of PerMed activities and related cultural aspects and health economy issues. By establishing technical taskforces and running a series of targeted workshops Sino-EU-PerMed will promote international standards and pave the way for future communication, collaboration and undertakings. Therefore the implementation of a dissemination plan is part of the project.
Our consortium and activities aim at maximising the unique and long-term impact PerMed approaches in cooperation and in alignment with ICPerMed. The cooperation with China set up and planned in Sino-EU-PerMed will allow ICPerMed to further strengthen Europe's leading role in this area and contribute to a successful implementation of PerMed in the global context and foster joint PerMed projects between Europe and China.

Fields of science

Keywords

Programme(s)

Topic(s)

Call for proposal

H2020-SC1-BHC-2018-2020

See other projects for this call

Sub call

H2020-SC1-2019-Single-Stage-RTD

Funding Scheme

CSA - Coordination and support action

Coordinator

DEUTSCHES ZENTRUM FUR LUFT - UND RAUMFAHRT EV
Net EU contribution
€ 1 344 368,50
Address
Linder hohe
51147 Koln
Germany

See on map
Region
Nordrhein-Westfalen Köln Köln, Kreisfreie Stadt
Activity type
Research Organisations
Links
Other funding
€ 0,00

Participants (5)

Share this page

Download

Last update: 18 August 2023

My Booklet

Permalink: https://cordis.europa.eu/project/id/874556

European Union, 2023